Tuesday, June 19, 2012

PGNX Stock Chart With Technical Analysis


I have posted above a stock chart for the Biotech company $PGNX, which had a FDA approval extension (3 months). Investors did not like that and the stock sold off. It is approaching its 3 month extension in late July/August, so it will be interesting to see if investors get back into the stock.

Just sharing a stock here that I might take a long position in.

Learn to trade in just 7 minutes a week watch this video.